Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Surrogate target cells expressing surface anti-idiotype antibody for the clinical evaluation of an internalizing CD22-specific antibody

Published:2015-01-02 Issue:1 Volume:7 Page:66-76
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Leung Shui-on¹,Gao Kai²,Wang Guang Yu²,Cheung Benny Ka-wa¹,Lee Kwan-yeung³,Zhao Qi⁴,Cheung Wing-Tai³,Wang Jun Zhi²

Affiliation:

1. Institute of Biomedical Sciences; Fudan University; Shanghai, China

2. National Institute for Food and Drug Control; Beijing, China

3. School of Biomedical Sciences; The Chinese University of Hong Kong; Hong Kong, China

4. Institute of Biomedicine and Biotechnology; Shenzhen Institutes of Advanced Technology; Chinese Academy of Sciences; Shenzhen, China

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.4161/19420862.2014.985519

Reference42 articles.

1. Pharmacokinetics and tolerability of human mouse chimeric anti-CD22 monoclonal antibody in Chinese patients with CD22-positive non-Hodgkin lymphoma

2. Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study

3. Treatment of systemic lupus erythematosus with epratuzumab

4. CD22 is a negative regulator of B-cell receptor signalling

5. CD22 negatively and positively regulates signal transduction through the B lymphocyte antigen receptor

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantitation and Identification of Therapeutic Anti-CD22 Monoclonal Antibodies in a Cell-Based ELISA Method;Antibodies;2022-08-16

2. An open-label, multiple-dose study to assess the preliminary pharmacokinetics, pharmacodynamics, clinical activity, and safety of human mouse chimeric anti-CD22 monoclonal antibody (SM03) in patients with rheumatoid arthritis;Int. Journal of Clinical Pharmacology and Therapeutics;2021-11-01

3. Pharmacokinetics, Pharmacodynamics and Preliminary Observations for Clinical Activity and Safety of Multiple Doses of Human Mouse Chimeric Anti-CD22 Monoclonal Antibody (SM03) in Chinese Patients with Systemic Lupus Erythematosus;Clinical Drug Investigation;2016-07-18

4. Advantages and applications of CAR-expressing natural killer cells;Frontiers in Pharmacology;2015-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3